undefined cover
undefined cover
The Incentives Structure in Research is Broken - with Tyler Golato, Molecule cover
The Incentives Structure in Research is Broken - with Tyler Golato, Molecule cover
Into The Metahealth

The Incentives Structure in Research is Broken - with Tyler Golato, Molecule

The Incentives Structure in Research is Broken - with Tyler Golato, Molecule

20min |23/04/2024
Play
undefined cover
undefined cover
The Incentives Structure in Research is Broken - with Tyler Golato, Molecule cover
The Incentives Structure in Research is Broken - with Tyler Golato, Molecule cover
Into The Metahealth

The Incentives Structure in Research is Broken - with Tyler Golato, Molecule

The Incentives Structure in Research is Broken - with Tyler Golato, Molecule

20min |23/04/2024
Play

Description

In today's episode, we're diving into the groundbreaking intersection of intellectual property and blockchain technology with a focus on IP NFTs. Joining us is Tyler Golato, the co-founder and CEO of Molecule, a pioneering company revolutionizing biomedical innovation through NFTs.


Tyler shares Molecule's mission to bridge the funding gap in biomedical research, particularly during the challenging "Valley of Death" phase. We explore how Molecule leverages web three technologies to incentivize early-stage research funding by digitizing intellectual property. Discover how researchers, patients, and advocacy groups collaborate to fund and own IP, reshaping the dynamics of translational funding.


Delving into the concept of IP-NFTs, Tyler demystifies the technology beyond its association with digital art, highlighting its role in making intellectual property natively transactable and governable. Beyond the IP-NFT protocol, we explore Molecule's ecosystem, including the Biotech IP Marketplace and BioDAO Launchpad, showcasing how these components amplify community-driven innovation.


What sets Molecule apart is its foundation in real industry needs, driven by individuals deeply embedded in biomedical research. Tyler's journey from biochemist to innovator underscores the authentic drive to solve real-world problems through web three solutions.


Join us as we unravel the potential of Web3 for research and science, inviting skeptics to explore its transformative power and get involved in shaping the future of healthcare. Tune in to gain insights into Molecule's vision and explore the dynamic landscape of Web3 in healthcare. Whether you're a researcher, entrepreneur, or passionate about driving change in healthcare, this episode offers a compelling glimpse into the possibilities of decentralized innovation.


Today's episode is brought to you in partnership with DeSci Nordics, the go-to event for decentralized science enthusiasts. Join us in Tallinn, Estonia, on April 25th. Don't miss out—register now to be part of the future of science.


Registration link: https://lu.ma/descinordics


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Description

In today's episode, we're diving into the groundbreaking intersection of intellectual property and blockchain technology with a focus on IP NFTs. Joining us is Tyler Golato, the co-founder and CEO of Molecule, a pioneering company revolutionizing biomedical innovation through NFTs.


Tyler shares Molecule's mission to bridge the funding gap in biomedical research, particularly during the challenging "Valley of Death" phase. We explore how Molecule leverages web three technologies to incentivize early-stage research funding by digitizing intellectual property. Discover how researchers, patients, and advocacy groups collaborate to fund and own IP, reshaping the dynamics of translational funding.


Delving into the concept of IP-NFTs, Tyler demystifies the technology beyond its association with digital art, highlighting its role in making intellectual property natively transactable and governable. Beyond the IP-NFT protocol, we explore Molecule's ecosystem, including the Biotech IP Marketplace and BioDAO Launchpad, showcasing how these components amplify community-driven innovation.


What sets Molecule apart is its foundation in real industry needs, driven by individuals deeply embedded in biomedical research. Tyler's journey from biochemist to innovator underscores the authentic drive to solve real-world problems through web three solutions.


Join us as we unravel the potential of Web3 for research and science, inviting skeptics to explore its transformative power and get involved in shaping the future of healthcare. Tune in to gain insights into Molecule's vision and explore the dynamic landscape of Web3 in healthcare. Whether you're a researcher, entrepreneur, or passionate about driving change in healthcare, this episode offers a compelling glimpse into the possibilities of decentralized innovation.


Today's episode is brought to you in partnership with DeSci Nordics, the go-to event for decentralized science enthusiasts. Join us in Tallinn, Estonia, on April 25th. Don't miss out—register now to be part of the future of science.


Registration link: https://lu.ma/descinordics


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Share

Embed

You may also like

Description

In today's episode, we're diving into the groundbreaking intersection of intellectual property and blockchain technology with a focus on IP NFTs. Joining us is Tyler Golato, the co-founder and CEO of Molecule, a pioneering company revolutionizing biomedical innovation through NFTs.


Tyler shares Molecule's mission to bridge the funding gap in biomedical research, particularly during the challenging "Valley of Death" phase. We explore how Molecule leverages web three technologies to incentivize early-stage research funding by digitizing intellectual property. Discover how researchers, patients, and advocacy groups collaborate to fund and own IP, reshaping the dynamics of translational funding.


Delving into the concept of IP-NFTs, Tyler demystifies the technology beyond its association with digital art, highlighting its role in making intellectual property natively transactable and governable. Beyond the IP-NFT protocol, we explore Molecule's ecosystem, including the Biotech IP Marketplace and BioDAO Launchpad, showcasing how these components amplify community-driven innovation.


What sets Molecule apart is its foundation in real industry needs, driven by individuals deeply embedded in biomedical research. Tyler's journey from biochemist to innovator underscores the authentic drive to solve real-world problems through web three solutions.


Join us as we unravel the potential of Web3 for research and science, inviting skeptics to explore its transformative power and get involved in shaping the future of healthcare. Tune in to gain insights into Molecule's vision and explore the dynamic landscape of Web3 in healthcare. Whether you're a researcher, entrepreneur, or passionate about driving change in healthcare, this episode offers a compelling glimpse into the possibilities of decentralized innovation.


Today's episode is brought to you in partnership with DeSci Nordics, the go-to event for decentralized science enthusiasts. Join us in Tallinn, Estonia, on April 25th. Don't miss out—register now to be part of the future of science.


Registration link: https://lu.ma/descinordics


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Description

In today's episode, we're diving into the groundbreaking intersection of intellectual property and blockchain technology with a focus on IP NFTs. Joining us is Tyler Golato, the co-founder and CEO of Molecule, a pioneering company revolutionizing biomedical innovation through NFTs.


Tyler shares Molecule's mission to bridge the funding gap in biomedical research, particularly during the challenging "Valley of Death" phase. We explore how Molecule leverages web three technologies to incentivize early-stage research funding by digitizing intellectual property. Discover how researchers, patients, and advocacy groups collaborate to fund and own IP, reshaping the dynamics of translational funding.


Delving into the concept of IP-NFTs, Tyler demystifies the technology beyond its association with digital art, highlighting its role in making intellectual property natively transactable and governable. Beyond the IP-NFT protocol, we explore Molecule's ecosystem, including the Biotech IP Marketplace and BioDAO Launchpad, showcasing how these components amplify community-driven innovation.


What sets Molecule apart is its foundation in real industry needs, driven by individuals deeply embedded in biomedical research. Tyler's journey from biochemist to innovator underscores the authentic drive to solve real-world problems through web three solutions.


Join us as we unravel the potential of Web3 for research and science, inviting skeptics to explore its transformative power and get involved in shaping the future of healthcare. Tune in to gain insights into Molecule's vision and explore the dynamic landscape of Web3 in healthcare. Whether you're a researcher, entrepreneur, or passionate about driving change in healthcare, this episode offers a compelling glimpse into the possibilities of decentralized innovation.


Today's episode is brought to you in partnership with DeSci Nordics, the go-to event for decentralized science enthusiasts. Join us in Tallinn, Estonia, on April 25th. Don't miss out—register now to be part of the future of science.


Registration link: https://lu.ma/descinordics


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Share

Embed

You may also like

undefined cover
undefined cover